We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+2.83%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.76B
AUM Growth
+$499M
(+6.9%)
Cap. Flow
+$366M
Cap. Flow
% of AUM
4.71%
Top 10 Holdings %
Top 10 Hldgs %
15.72%
Holding
1,667
New
74
Increased
571
Reduced
929
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$48.8M |
| 2 |
Healthpeak Properties
DOC
|
+$16.2M |
| 3 |
Clorox
CLX
|
+$16.1M |
| 4 |
Brown-Forman Class B
BF.B
|
+$14.4M |
| 5 |
Hormel Foods
HRL
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$36.9M |
| 2 |
Apple
AAPL
|
+$10.8M |
| 3 |
JPMorgan Chase
JPM
|
+$6.74M |
| 4 |
Microsoft
MSFT
|
+$6.53M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$5.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.62% |
| 2 | Technology | 13.27% |
| 3 | Financials | 13.22% |
| 4 | Consumer Staples | 11.59% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Neurocrine Biosciences
NBIX
$17.4B
| $3.05M | 0.04% |
67,146
-9,021
| -12% | -$415K |
|
352
Cullen/Frost Bankers
CFR
$10.2B
| $3.05M | 0.04% |
47,829
+17,488
| +58% | +$1.08M |
|
353
Citizens Financial Group
CFG
$30.2B
| $3.04M | 0.04% |
152,239
+15,861
| +12% | +$352K |
|
354
Norfolk Southern
NSC
$75.2B
| $3.04M | 0.04% |
35,707
+4,933
| +16% | +$419K |
|
355
American Water Works
AWK
$26.1B
| $3.04M | 0.04% |
35,953
+15,722
| +78% | +$1.17M |
|
356
KLA
KLAC
$271B
| $3.02M | 0.04% |
412,910
-7,520
| -2% | -$53.9K |
|
357
Constellation Brands
STZ
$22.9B
| $3.02M | 0.04% |
18,252
-1,817
| -9% | -$284K |
|
358
MDU Resources
MDU
$4.36B
| $3M | 0.04% |
328,722
+175,531
| +115% | +$1.43M |
|
359
Williams Companies
WMB
$90.7B
| $2.99M | 0.04% |
138,195
-29,823
| -18% | -$599K |
|
360
Bank OZK
OZK
$5.61B
| $2.98M | 0.04% |
79,484
+32,611
| +70% | +$1.29M |
|
361
FirstEnergy
FE
$28.1B
| $2.97M | 0.04% |
85,098
-460
| -0.5% | -$15.6K |
|
362
Casey's General Stores
CASY
$32.1B
| $2.96M | 0.04% |
22,545
+3,366
| +18% | +$391K |
|
|
EV
363
DELISTED
Eaton Vance Corp.
EV
| $2.96M | 0.04% |
83,745
+33,955
| +68% | +$1.19M |
|
364
NOV
NOV
$7.02B
| $2.96M | 0.04% |
87,885
-11,192
| -11% | -$359K |
|
365
Sempra
SRE
$59.3B
| $2.92M | 0.04% |
51,134
-2,616
| -5% | -$139K |
|
366
Nasdaq
NDAQ
$52B
| $2.9M | 0.04% |
134,514
-2,289
| -2% | -$48.9K |
|
367
Labcorp
LH
$23.1B
| $2.9M | 0.04% |
25,898
-865
| -3% | -$93.1K |
|
368
Zimmer Biomet
ZBH
$17.4B
| $2.9M | 0.04% |
24,794
+2,921
| +13% | +$331K |
|
369
A.O. Smith
AOS
$8.12B
| $2.87M | 0.04% |
65,210
+30,786
| +89% | +$1.24M |
|
370
International Paper
IP
$19.2B
| $2.85M | 0.04% |
71,151
-4,846
| -6% | -$193K |
|
371
West Pharmaceutical
WST
$24.9B
| $2.84M | 0.04% |
37,434
-536
| -1% | -$39K |
|
372
Acadia Pharmaceuticals
ACAD
$4.29B
| $2.83M | 0.04% |
87,199
-8,397
| -9% | -$281K |
|
|
STJ
373
DELISTED
St Jude Medical
STJ
| $2.83M | 0.04% |
36,264
-15,322
| -30% | -$1.09M |
|
|
VAL
374
DELISTED
Valspar
VAL
| $2.82M | 0.04% |
26,144
+10,306
| +65% | +$1.11M |
|
375
Unum
UNM
$14.2B
| $2.81M | 0.04% |
88,500
-8,526
| -9% | -$288K |
|
Similar funds
ProShare Advisors's Q2 2016 Portfolio in Review
As of Q2 2016, ProShare Advisors held 1,667 positions worth $7.76B, up 6.9% from $7.26B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors deployed $366M of net new capital in Q2 2016, opening 74 new positions and adding to 571 existing holdings. Its largest new stake was S&P Global: 454,450 shares worth $48.7M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $10.8M trimmed.
- ProShare Advisors's largest Q2 2016 buy was S&P Global: 454,450 shares worth $48.7M.
- ProShare Advisors added most to Healthpeak Properties in Q2 2016, an estimated $16.2M increase.
- ProShare Advisors's biggest Q2 2016 reduction was Apple, cutting an estimated $10.8M.
- ProShare Advisors fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $36.9M.
- ProShare Advisors's ten largest holdings make up 16% of its $7.76B portfolio in Q2 2016.
- ProShare Advisors opened 74 new positions and closed 86 in Q2 2016.
- ProShare Advisors's portfolio value rose 6.9% quarter-over-quarter to $7.76B.
Based on ProShare Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.